The lawsuits come as Eli Lilly grapples with a shortage of Mounjaro in the U.S. due to skyrocketing demand.
Eli Lilly sues clinics allegedly selling knockoff versions of Mounjaro diabetes drug
Market Pulse
- : TikTok parent ByteDance turns $6 billion operating profit in 2023’s first quarter: WSJ02/10/2023
- : Stocks end mostly higher Monday despite resumed U.S. debt selloff02/10/2023
- : Dow, S&P 500 set to extend last week’s losses in Monday’s final hour of trading02/10/2023
- : U.S. oil futures post lowest finish since mid-September02/10/2023
- : 3M stock descends toward an 11-year low as PFAS concerns continue02/10/2023
- : U.S. stocks open mostly lower as Treasury yields jump after Washington averts government shutdown02/10/2023
- : Treasury yields head back toward multiyear highs after U.S. government averts shutdown02/10/2023
- : Stocks of both former-Kellogg Kellanova, and new WK Kellogg fall on first day after separation completed02/10/2023
- : Insulet shares rise as analysts say weight-loss drug fears may be overblown02/10/2023
- : Rivian delivers 15,564 EVs in Q3, more than double that of a year ago02/10/2023
